BIOVICA Trademark

Trademark Overview


On Wednesday, April 27, 2022, a trademark application was filed for BIOVICA with the United States Patent and Trademark Office. The USPTO has given the BIOVICA trademark a serial number of 97384814. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, August 2, 2024. This trademark is owned by Biovica International AB. The BIOVICA trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

(Based on 44(e)) Diagnostic agents and reagents, preparations and substances for medical and veterinary purposes for the measurement of cell division; diagnostic agents and reagents, preparations and substances for measuring enzyme activity for medical and veterinary purposes; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in cancer therapy; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in viral diseases; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in autoimmune diseases

(Based on Use in Commerce) Diagnostic preparations for scientific or research use; diagnostic agents and reagents for scientific or research use

(Based on 44(e)) Medical, biomedical and veterinary diagnostic monitoring and testing services regarding blood serum or plasma samples or cell cultures; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of cell proliferation; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of enzymatic activity; provision of medical information and advice relating to the use of medical and veterinary diagnostic equipment; medical testing for diagnostic or treatment purposes, namely, conducting tests to identify diseases affecting cell division, cancer, viral and autoimmune diseases; medical analysis regarding the identification and monitoring of cancer, virus and autoimmune diseases and other diseases that cause cell growth for the diagnosis and treatment of persons

(Based on 44(e)) Scientific laboratory services and scientific research and analysis regarding monitoring and predicting treatment response to cancer therapy, and in viral therapy and autoimmune therapy; scientific laboratory services and research and analysis regarding measuring the activity of enzyme in blood serum or cell cultures; research and development in the field of diagnostic preparations; scientific research and development, namely, diagnostic development; data science services, namely, compiling data for research purposes in the field of biostatistics; laboratory biomarker analysis services and related data analysis; biochemical analysis; medical laboratory services; conducting preclinical studies in the nature of scientific feasibility studies; medical laboratory services regarding measurement of cell division; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of cell proliferation; medical laboratory services regarding measuremen...
biovica

General Information


Serial Number97384814
Word MarkBIOVICA
Filing DateWednesday, April 27, 2022
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, August 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 14, 2023

Trademark Statements


Goods and Services(Based on 44(e)) Diagnostic agents and reagents, preparations and substances for medical and veterinary purposes for the measurement of cell division; diagnostic agents and reagents, preparations and substances for measuring enzyme activity for medical and veterinary purposes; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in cancer therapy; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in viral diseases; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in autoimmune diseases
Goods and Services(Based on Use in Commerce) Diagnostic preparations for scientific or research use; diagnostic agents and reagents for scientific or research use
Goods and Services(Based on 44(e)) Medical, biomedical and veterinary diagnostic monitoring and testing services regarding blood serum or plasma samples or cell cultures; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of cell proliferation; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of enzymatic activity; provision of medical information and advice relating to the use of medical and veterinary diagnostic equipment; medical testing for diagnostic or treatment purposes, namely, conducting tests to identify diseases affecting cell division, cancer, viral and autoimmune diseases; medical analysis regarding the identification and monitoring of cancer, virus and autoimmune diseases and other diseases that cause cell growth for the diagnosis and treatment of persons
Goods and Services(Based on 44(e)) Scientific laboratory services and scientific research and analysis regarding monitoring and predicting treatment response to cancer therapy, and in viral therapy and autoimmune therapy; scientific laboratory services and research and analysis regarding measuring the activity of enzyme in blood serum or cell cultures; research and development in the field of diagnostic preparations; scientific research and development, namely, diagnostic development; data science services, namely, compiling data for research purposes in the field of biostatistics; laboratory biomarker analysis services and related data analysis; biochemical analysis; medical laboratory services; conducting preclinical studies in the nature of scientific feasibility studies; medical laboratory services regarding measurement of cell division; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of cell proliferation; medical laboratory services regarding measurement of enzymatic activity; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of enzymatic activity

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code001
First Use Anywhere DateFriday, March 24, 2023
First Use In Commerce DateFriday, March 24, 2023

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiovica International AB
Party Type20 - Owner at Publication
Legal Entity Type64 - NOT AVAILABLE
AddressUppsala SE-75237
SE

Party NameBiovica International AB
Party Type10 - Original Applicant
Legal Entity Type64 - NOT AVAILABLE
AddressUppsala SE-75237
SE

Trademark Events


Event DateEvent Description
Monday, October 10, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, April 30, 2022NEW APPLICATION ENTERED
Tuesday, May 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 10, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 10, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 10, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, October 10, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 10, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 31, 2023ASSIGNED TO EXAMINER
Thursday, February 2, 2023NON-FINAL ACTION WRITTEN
Thursday, February 2, 2023NON-FINAL ACTION E-MAILED
Thursday, February 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 10, 2023ASSIGNED TO LIE
Tuesday, July 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 21, 2024TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, July 3, 2024USE AMENDMENT FILED
Wednesday, July 3, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 3, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, July 3, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 2, 2024STATEMENT OF USE PROCESSING COMPLETE